A plain-English guide to Wegovy — what it is, how it works, who it’s for, and what to expect.
If Ozempic is the drug everyone has heard of, Wegovy is what most people actually need. Same active ingredient, different purpose, higher dose, and now available in both injection and pill form. Yet a lot of people are still confused about what makes Wegovy different.
This guide breaks it all down clearly.
What Is Wegovy?
Wegovy is a prescription weight-loss medication made by Novo Nordisk. Its active ingredient is semaglutide — the same molecule found in Ozempic — but formulated at a higher dose specifically for chronic weight management.
It comes in two forms:
- Weekly injection — a pre-filled pen injected once a week under the skin
- Daily pill — the first oral GLP-1 receptor agonist approved specifically for obesity, launched in early 2026 at approximately $149/month
What Is Wegovy Approved to Treat?
Wegovy is FDA-approved for three uses:
1. Chronic weight management
For adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes.
2. Reducing cardiovascular risk
Wegovy is used to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
3. Weight management in adolescents
Wegovy injection is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep it off. Note: the Wegovy pill is not approved for adolescents.
Important: Unlike Ozempic, Wegovy is specifically FDA-approved for weight loss — you do not need a type 2 diabetes diagnosis to be prescribed it.
How Does Wegovy Work?
Wegovy works like the GLP-1 hormone your body naturally produces after eating — helping to regulate appetite and calorie intake. Specifically, it:
- Signals your pancreas to release insulin when blood sugar rises after eating
- Slows digestion — food moves through your stomach more slowly, keeping you full for longer
- Reduces appetite in the brain — hunger signals become weaker, portions feel satisfying at smaller sizes
- Quiets food noise — the constant mental chatter about food that drives overeating disappears for most people. Read more about food noise →
How Is Wegovy Taken?
Injection (once weekly)
Wegovy is injected once a week under the skin in the belly, thigh, or upper arm. You can take it at any time of day, with or without food. Same day, every week.
Pill (once daily)
Wegovy pills are taken once daily in the morning. Tablets should be swallowed whole — not split, crushed, chewed, or dissolved. The pill must be taken on an empty stomach, at least 30 minutes before eating, drinking anything other than a small sip of water, or taking other medications. Food significantly reduces absorption.
Wegovy Dosing Schedule (injection)
| Phase | Dose | Duration |
|---|---|---|
| Starter | 0.25 mg/week | Weeks 1–4 |
| Step 1 | 0.5 mg/week | Weeks 5–8 |
| Step 2 | 1.0 mg/week | Weeks 9–12 |
| Step 3 | 1.7 mg/week | Weeks 13–16 |
| Maintenance | 2.4 mg/week | Week 17 onward |
To reduce the risk of gut symptoms, the weekly dose is gradually increased over 16 weeks. Never skip steps or increase dose faster than prescribed — this is the main cause of severe nausea.
What Results Can You Expect?
Results from clinical trials:
- Wegovy injection (STEP 1 trial): Average 14.9% total body weight loss over 68 weeks
- Wegovy pill (OASIS 4 trial): Average weight loss of approximately 16.6% after 64 weeks, compared with 3% in the placebo group
- Cardiovascular: Adults with obesity and established heart disease who took semaglutide once a week had about a 20% lower risk of heart attack, stroke, or cardiovascular-related death
Individual results vary significantly based on diet, exercise, starting weight, and dose reached.
Wegovy vs. Ozempic — What’s the Difference?
Both contain semaglutide. Here’s how they differ:
| Wegovy | Ozempic | |
|---|---|---|
| Approved for | Weight management | Type 2 diabetes |
| Max injection dose | 2.4 mg/week | 2 mg/week |
| Pill available | Yes (25mg daily) | Yes (coming 2026) |
| For non-diabetics | Yes | Not officially |
| Adolescent use | Yes (12+, injection only) | No |
For a full three-way comparison, read Ozempic vs Wegovy vs Mounjaro →
Who Should NOT Take Wegovy?
Do not use Wegovy if you have or have had:
- A personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- A serious allergic reaction to semaglutide
- Problems with your pancreas or kidneys
- Depression, suicidal thoughts, or mental health issues — monitor closely
- Surgery or procedures using anesthesia planned soon — discuss timing with your doctor
- Pregnancy or plans to become pregnant — stop Wegovy at least 2 months before trying to conceive
Side Effects of Wegovy
Most Common
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Stomach pain
- Fatigue
These are most common when starting or after a dose increase, and typically improve over time. See our full guide on managing nausea on GLP-1 →
Serious Side Effects — Contact Your Doctor Immediately
- Pancreatitis — severe persistent abdominal pain radiating to back
- Gallbladder problems — upper abdominal pain, fever, jaundice
- Vision changes — report any changes immediately
- Kidney problems — especially if dehydrated from nausea/vomiting
- Serious allergic reaction — facial swelling, difficulty breathing — seek emergency care
- Thyroid tumors — lump in neck, hoarseness, difficulty swallowing
Common Concerns From Real Users
- Hair loss — caused by rapid weight loss, not Wegovy itself. Temporary. Full guide →
- Muscle loss — protect it with protein and resistance training. Full guide →
- Alcohol — hits harder, and most people lose interest in drinking. Full guide →
How Much Does Wegovy Cost?
The Wegovy pill launched at approximately $149/month in early 2026 — a fraction of the cost of the injection.
For the injection:
- With insurance and savings card: as little as $25/month
- Without insurance through NovoCare: from $199/month introductory, $299–$349/month ongoing
- Compounded semaglutide alternatives: from $150–$299/month through telehealth
Only 19% of large employer plans covered GLP-1s for weight loss in 2025 — making cost the biggest barrier for most people.
Will I Regain Weight if I Stop Wegovy?
In one study, participants who stopped Wegovy after 20 weeks regained 7% of body weight over the following 48 weeks, while those who continued on Wegovy lost a further 8%. For most people, Wegovy is a long-term treatment — similar to medication for blood pressure or cholesterol. The goal during treatment is to build habits that support you if and when you stop.
Is Wegovy Right for You?
Come to your appointment prepared:
- Know your current BMI and any weight-related conditions
- Be ready to discuss your cardiovascular history
- Ask about injection vs pill — both are now available
- Ask whether the savings card applies to your situation
- Discuss realistic timelines and expectations
Not sure where to start? Find a telehealth provider →
The Bottom Line
Wegovy is the weight-loss focused version of semaglutide — the same molecule as Ozempic, at a higher dose, with FDA approval specifically for chronic weight management. It’s now available as both a weekly injection and a daily pill. Clinical trials show average weight loss of 15–17% of body weight over 12–16 months.
It works by mimicking the GLP-1 hormone — reducing appetite, slowing digestion, quieting food noise, and improving how the body handles blood sugar.
If you’re considering starting, this is where to go next:
Medical Disclaimer
The content on this page is for informational and educational purposes only. It reflects general user experiences and publicly available clinical information about GLP-1 medications — not personal medical advice. Every person’s health situation is different. Before starting, adjusting, or stopping any medication or treatment, please consult a licensed healthcare provider or specialist who can evaluate your individual circumstances.